NCT05768815

Brief Summary

The goal of this clinical trial is to compare the effectiveness of the Breaking the Cycle (BTC) and Maxxine Wright (MW) programs in substance-involved mothers and their children. One key difference between the two programs is that the BTC program contains an infant mental health component while the MW program primarily focuses on the mothers. The main questions the trial aims to answer are:

  • Do children at BTC demonstrate enhanced infant mental health compared to children at MW up to 2 years post-intervention?
  • Do mother-child dyads at BTC experience more decreases in child adverse childhood experiences (ACE), maternal stress, and mental health symptoms and have better home environment scores, parenting attitudes, and mother-child relationship scores compared to mother-child dyads at MW?
  • Are enhanced infant mental health outcomes associated with children's lower psychosocial risk scores and mothers with lower ACE scores, lower depression and anxiety scores, and lower maternal stress?
  • Are the associations between treatment dose and infant mental health scores mediated by parenting attitudes and the mother-child relationship? Does child exposure to psychosocial risk moderate the association between treatment dose and child outcomes?
  • How do the mechanisms of change lead to the effectiveness of BTC? What are the potential lifetime health and non-health outcomes of at-risk children at BTC? What is the long-term social return on investment (SROI) of BTC? Participants will complete several questionnaires at three timepoints while receiving services at either BTC or MW: during the intake phase, 12 months after their engagement in services and 24 months after their engagement in services. Given that the two programs serve a similar demographic of women, researchers will compare the BTC group and the MW group to establish the comparative effectiveness and mechanisms of change of the infant mental health component of BTC.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

February 23, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 14, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

September 28, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 23, 2024

Status Verified

March 1, 2024

Enrollment Period

2.9 years

First QC Date

February 23, 2023

Last Update Submit

May 22, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Children's socio-emotional functioning will be measured using the Ages and Stages Questionnaire-Social Emotional (ASQ-SE-2)

    The ASQ-SE-2 is a 26-item, parent-completed questionnaire that is highly reliable and focuses solely on social-emotional development in young children aged 1-72 months.

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

  • Children's developmental functioning will be measured using the Ages and Stages Questionnaire-Third Edition (ASQ-3)

    The ASQ-3 consists of a series of parent-completed questionnaires to assess child development across five domains for children 1 to 66 months: communication, gross motor, fine motor, problem-solving, and personal-social skills.

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

Secondary Outcomes (11)

  • Children's exposure to risk and protective factors will be measured using a cumulative risk measure (Bondi et al., 2020)

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

  • Sensitivity of maternal behaviour will be measured using the Maternal Behavior Q-Sort (MBQS) Brief Version

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

  • Maternal stress will be measured using the Parenting Stress Index Short Form (PSI-4-SF)

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

  • Parenting attitudes will be measured using the Adult-Adolescent Parenting Inventory Version 2.0 (AAPI-2)

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

  • Self-efficacy and satisfaction as a parent will be measured using the Being a Parent Scale

    Change from pre-intervention to 12 months after engagement and 24 months after engagement

  • +6 more secondary outcomes

Study Arms (2)

Breaking the Cycle Intervention group

EXPERIMENTAL
Behavioral: Breaking the Cycle Program

Maxxine Wright Intervention group

ACTIVE COMPARATOR
Behavioral: Maxxine Wright Program

Interventions

BTC is a prevention and early intervention program in Toronto, Canada, serving substance-using pregnant and/or parenting women with children under six years of age. Established by the Canadian Mothercraft Society in 1995, BTC is funded by the Community Action Program for Children and the Canadian Prenatal Nutrition Program through the Public Health Agency of Canada. BTC provides three program components that act synergistically: a) individualized services for mothers, b) individualized services for children, and c) relational interventions that enhance the mother-child relationship and promote infant mental health. Coordinated supports are offered through formal partnerships across service sectors. In 2004, BTC was recognized by the United Nations as an exemplary program serving pregnant and parenting women with substance use problems, and their young children.

Breaking the Cycle Intervention group

Founded in 2005 and located in Surrey, British Columbia, the Maxxine Wright Community Health Centre (MWCHC) supports women who are pregnant and/or have young children and are impacted by substance use and/or violence. Women do not need to have children in their care to receive services. The program is funded and operated by the Fraser Health Authority, with additional in-kind support from the BC Ministry for Children and Family Development and the BC Ministry of Social Development and Poverty Reduction. MW addresses maternal substance use and exposure to violence through women-centered, trauma-informed, culturally grounded, and interdisciplinary approaches. Primary services offered include addiction counselling, primary health care, and group therapy to address interpersonal violence. Within MW, child-focused services are limited to primary health (e.g., well baby checks, childcare).

Maxxine Wright Intervention group

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • receiving services at either BTC or MW
  • having a child under the age of 6 years
  • being able to answer a questionnaire in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Maxxine Wright Community Health Centre

Surrey, British Columbia, V3V 1H9, Canada

RECRUITING

Mothercraft, Breaking the Cycle

Toronto, Ontario, M5A 1L3, Canada

RECRUITING

Related Publications (1)

  • Racine N, Barriault S, Motz M, Leslie M, Poole N, Premji S, Andrews NCZ, Penaloza D, Pepler D. A comparative effectiveness study of the breaking the cycle and Maxxine Wright intervention programs for substance-involved mothers and their children: study protocol. BMC Psychol. 2024 Jan 5;12(1):16. doi: 10.1186/s40359-023-01484-w.

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Central Study Contacts

Nicole Racine, PhD, C.Psych

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2023

First Posted

March 14, 2023

Study Start

September 28, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 23, 2024

Record last verified: 2024-03

Locations